Ink

HOFA Returns to Art Central 2024 With Eight Exceptional International Artists

Retrieved on: 
Wednesday, March 27, 2024
Element, Chung, Documentation, Environment, Ink, Motion, Photography, Software, Nature, Heart, Movement, Breakfast, Hong Kong, Industrial design

HONG KONG, Mar 27, 2024 - (ACN Newswire) - HOFA Gallery returns to Art Central Hong Kong from 28 to 31 of March 2024, eager to captivate audiences at Booth B11 with a showcase titled 'Abstract Actuality'.

Key Points: 
  • HONG KONG, Mar 27, 2024 - (ACN Newswire) - HOFA Gallery returns to Art Central Hong Kong from 28 to 31 of March 2024, eager to captivate audiences at Booth B11 with a showcase titled 'Abstract Actuality'.
  • Her commanding perspective deftly manipulates precision, depth, and space, evoking elusive imagery that invites interpretation through the lens of each individual's perspective.
  • Regarded as a refuge from the world's noise, Hannes Schauer's art serves as a space for quiet contemplation, akin to communing with nature.
  • 'Abstract Actuality' HOFA Gallery (Booth B11) Art Central, Hong Kong, 28 - 31 March 2024

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Retrieved on: 
Monday, April 8, 2024
Computational biology, Malignancy, Canadian Aviation Regulations, Gene editing, Bone disease, Cell, Hook effect, CXCR4, Enfortumab vedotin, Synthetic biology, Patient, Neoplasm, Epitope, Differentiable function, Ink, PBMC, Protein engineering, HLA, Science, Cytotoxicity, AACR, Phenotype, Therapy, IPSC, Skin, Inflammation, Prognosis, Carcinogenesis, Rejection, CD22, VHH, Poster, NK, Century, Autoimmunity, Bone marrow, Engineering, CD19, Vaccine

PHILADELPHIA, April 08, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that preclinical data from the Company’s iPSC-derived cell therapy platform was presented at the AACR Annual Meeting 2024.

Key Points: 
  • PHILADELPHIA, April 08, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that preclinical data from the Company’s iPSC-derived cell therapy platform was presented at the AACR Annual Meeting 2024.
  • This novel CAR was engineered and tested in iPSC-derived gamma-delta T cells, showing in vitro tumor cell cytotoxicity.
  • These findings support the continued examination of a CD19xCD22 bispecific CAR for off-the-shelf allogeneic cell therapy to expand patient access beyond CD19 CAR-T cell therapies.
  • In these preclinical studies, Century identified novel single-domain antibodies (VHH) that bind to multiple epitopes on the NECTIN4 extracellular domain.

Trian Reaffirms Its Call for Change at Disney and the Commitment of Its Director Candidates to Work Collaboratively with Members of the Disney Board

Retrieved on: 
Monday, March 25, 2024
Institutional Shareholder Services, Culture, Growth, Exercise, The New York Times, CFO, Knowledge, CNBC, Ink, Judgement, Thought, ISS, Retirement, Procter & Gamble, The Wall Street Journal, Magic, Toy

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- The Trian Group,1 which beneficially owns over $3.5 billion of common stock in The Walt Disney Company (NYSE: DIS), today reaffirmed its call for change in the composition of the Board of Directors of Disney and the commitment of its nominees, Nelson Peltz and Jay Rasulo, to work constructively with the Company’s Board and leadership team to drive long-term, sustainable value creation.

Key Points: 
  • Trian believes Disney’s problems lay at the feet of the Board, which lacks focus, alignment and accountability.
  • Although the Board members are accomplished professionals, they are extraordinarily busy, have invested almost none of their own money in Disney stock and have failed to heed investor input.
  • In 2019, Mr. Peltz was asked by Mr. Iger to address the Disney Board about shareholder sentiment in the media industry.
  • Trian is convinced that Mr. Peltz and Mr. Rasulo can assist Disney with its challenges and help ensure a brighter future.

Global Artificial Intelligence Market Expected to Grow to $1.3 Trillion by 2023

Retrieved on: 
Monday, March 18, 2024
Cloud, MSFT, Combination, Google Cloud, Algorithm, Natural language processing, Microsoft, Health, Ink, Social media, Artificial intelligence, Transport, Business analyst, Alphabet Inc., AV1, USD, Marketing, Cloud database, Armada, Automation, Amazon, Partnership, Internet of things, Oracle Cloud, VMW, PALM, BMR, Ministry of Investment, Hallucination, HP, VMware, Register, Microsoft Azure, Organization, Intelligence, Library, Internet, Research, News, Acquisition, PostgreSQL, KSA, Alliance for Open Media, Robotics, ACM, GOOG, ChatGPT, Machine learning, MISA, AACI, Nvidia, Growth, HP Inc., CUDA, NVDA, OCI, Table, A.I, Big, NVIDIA, Medical device

A report from MarketsAndMarkets said that the global artificial intelligence market size was valued at USD 150.2 billion in 2023 and is expected to grow at a CAGR of 36.8% from 2023 to 2030.

Key Points: 
  • A report from MarketsAndMarkets said that the global artificial intelligence market size was valued at USD 150.2 billion in 2023 and is expected to grow at a CAGR of 36.8% from 2023 to 2030.
  • The report added: “The increasing adoption of autonomous artificial intelligence (AI) is driving the growth of the Artificial Intelligence Industry.
  • As technology advances and more industries recognize its benefits, the Artificial Intelligence (AI) Market size is poised for expansion, fostering innovation and new opportunities.”   Active A.I.
  • MarketsAndMarkets continued: “The exponential ai growth statistics of digital data from various sources presents immense opportunities for the AI market.

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, March 14, 2024
EGFR, Gene editing, Cell, Immunotherapy, Patient, BMS, SLE, Bristol Myers Squibb, Protein engineering, IND, Investment, Therapy, CRS, Lymphoma, Research, Computational biology, ASH, Pharming, Investigational New Drug, IPSC, Cancer, Safety, Inflammation, Food, Cetuximab, AACR, Research and development, GAAP, NK, FDA, Administration, Ink, MBA, Abstract, Society, Rejection, Century, Autoimmunity, Pharmaceutical industry

PHILADELPHIA, March 14, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today reported financial results and business highlights for the full year ended December 31, 2023.

Key Points: 
  • In December 2023, Century presented initial clinical data from the Phase 1 ELiPSE-1 Trial of CNTY-101 in relapsed/refractory (r/r) B-cell lymphomas.
  • Data showed that CNTY-101 was well-tolerated at Dose Level 1 (100 million cells) in high-risk, heavily pretreated R/R B-cell lymphoma patients.
  • Net Loss: Net loss was $136.7 million for the year ended December 31, 2023, compared to $131.0 million for the year ended December 31, 2022.
  • The Company expects full year generally accepted accounting principles (GAAP) operating expenses to be between $135 million and $145 million.

Trian Comments on The Walt Disney Company’s Disingenuous and Hyperbolic Rhetoric

Retrieved on: 
Wednesday, March 13, 2024
Disney Streaming, CFO, Annual general meeting, History, Ink, Acquisition, Investment, Fox, Magic, Film industry

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. has nominated two candidates, Nelson Peltz and Jay Rasulo, for election to the Board of Directors of The Walt Disney Company (NYSE: DIS). Trian opposes the reelection of two of Disney’s incumbent directors, Michael B.G. Froman and Maria Elena Lagomasino. Trian and Disney have been advocating for their respective director candidates and soliciting votes from Disney shareholders ahead of the Company’s 2024 Annual Meeting of Shareholders, which will be held on April 3.

Key Points: 
  • Trian and Disney have been advocating for their respective director candidates and soliciting votes from Disney shareholders ahead of the Company’s 2024 Annual Meeting of Shareholders, which will be held on April 3.
  • Trian loves The Walt Disney Company and believes it has unparalleled assets and opportunities and every reason to grow and prosper.
  • He owns more than $2.5 billion of Disney stock;8 he, like all shareholders, wants Disney to improve and create value.
  • Given Disney’s many competitive advantages, Trian is convinced Disney can outperform for shareholders in the future.

Videojet Introduces a New Large Character Inkjet Printer for Case and Carton Coding

Retrieved on: 
Wednesday, April 3, 2024
Other Retail, Supply Chain Management, Technology, Manufacturing, Other Technology, Other Manufacturing, Retail, Software, Networks, Packaging, Hardware, Wi-Fi, Printing, Ink, Dust, HMI, ZPL, USB, 3D printing

With over 45 years of expertise in inkjet printing technology, Videojet Technologies is pleased to launch the new Videojet 2380 high-resolution large character inkjet printer for manufacturers and distributors with on-demand case coding requirements.

Key Points: 
  • With over 45 years of expertise in inkjet printing technology, Videojet Technologies is pleased to launch the new Videojet 2380 high-resolution large character inkjet printer for manufacturers and distributors with on-demand case coding requirements.
  • The Videojet 2380 inkjet printer offers a complete solution for printing on corrugated cardboard cases, cartons, shipping containers and other porous materials.
  • This versatile carton and cardboard box printer adapts to users’ unique marking and coding requirements.
  • For more information about the Videojet 2380 large character inkjet printer, visit: www.videojet.com/2380 .

HP Instant Ink Review (2024): Top Ink Subscription Service Reviewed by Compare Before Buying

Retrieved on: 
Thursday, March 28, 2024
Office Products, Environment, Hardware, Recycling, Consumer Electronics, Technology, Retail, Delivery Services, Rigidity, Printing, Ink, Internet, Hand, HP

Compare Before Buying has published its HP Instant Ink review , offering a closer look at the top ink subscription service designed to streamline printer maintenance and ink replenishment for both personal and office use.

Key Points: 
  • Compare Before Buying has published its HP Instant Ink review , offering a closer look at the top ink subscription service designed to streamline printer maintenance and ink replenishment for both personal and office use.
  • HP Instant Ink is a subscription service that takes the guesswork and hassle out of buying printer ink.
  • Subscribers who choose to cancel their HP Instant Ink service can still use their printer with regular ink cartridges available from HP or other retailers.
  • For more information on the HP Instant Ink service and to read the full review, visit Compare Before Buying's website .

Best Printer Ink Subscription Services (2024): HP Instant Ink Review Published by Compare Before Buying

Retrieved on: 
Wednesday, March 27, 2024
Technology, Mobile, Wireless, Hardware, Consumer Electronics, Control, Printing, Business, Ink, Political moderate, Habit, HP, 3D printing

In a recent article by Compare Before Buying, HP Instant Ink stands out as the premier choice in printer ink subscriptions.

Key Points: 
  • In a recent article by Compare Before Buying, HP Instant Ink stands out as the premier choice in printer ink subscriptions.
  • Some of the key features that set HP Instant Ink apart include:
    Savings: HP Instant Ink offers significant savings on ink, catering to both home users and small businesses with plans tailored to various needs.
  • Despite these considerations, HP Instant Ink emerges as the top choice for printer ink subscription services, offering unparalleled savings, convenience, and flexibility to users worldwide.
  • For more information, please visit Compare Before Buying's review on the best printer ink subscription services featuring HP Instant Ink.

Hitachi Achieves Paperless Operations with E Ink’s eNotes

Retrieved on: 
Tuesday, March 26, 2024
Environment, Technology, Security, Software, Sustainability, Networks, Hardware, IOT (Internet of Things), Supply Chain Management, Retail, Carbon, Quality control, Science Based Targets initiative, Printing, Internet of things, GHG, Ink, Grace note, Carbon footprint, Science, Hitachi, Workflow, E Ink, ENotes, Multimedia, Targets

E Ink (8069.TW) the originator, pioneer, and global commercial leader in ePaper technology, today announced its collaboration with Hitachi, Ltd. to achieve digital transformation and paperless operations in manufacturing sites at Omika Works.

Key Points: 
  • E Ink (8069.TW) the originator, pioneer, and global commercial leader in ePaper technology, today announced its collaboration with Hitachi, Ltd. to achieve digital transformation and paperless operations in manufacturing sites at Omika Works.
  • E Ink is helping to improve workflow and efficiency by deploying eNotes developed by E Ink's subsidiary, Linfiny Japan Inc., on Hitachi's IoT platform.
  • View the full release here: https://www.businesswire.com/news/home/20240322112059/en/
    The eNote developed by E Ink subsidiary Linfiny Japan Inc. can help improve workflow and increase efficiency.
  • The introduction of ePaper has proven not only to enable paperless operations but also to prevent checks from being omitted and to enhance management through the utilization of the input data.